Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
European Journal of Neurology
|
January 31, 2026
EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemia
T Kyriakides, K Aleksovska, C Angelini, et al.
Journal of Neuromuscular Diseases
|
November 25, 2017
Early-Onset Myopathies: Clinical Findings, Prevalence of Subgroups and Diagnostic Approach in a Single Neuromuscular Referral Center in Germany
K Vill, A Blaschek, D Gläser, et al.
European Journal of Neurology
|
May 7, 2017
European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience
A T van der Ploeg, M E Kruijshaar, A Toscano, et al.
Neuropathology and Applied Neurobiology
|
September 24, 2019
An integrative correlation of myopathology, phenotype and genotype in late onset Pompe disease
M Kulessa, I Weyer-Menkhoff, L Viergutz, et al.
Acta Neuropathologica Communications
|
February 5, 2016
New insights into the protein aggregation pathology in myotilinopathy by combined proteomic and immunolocalization analyses
A Maerkens, M Olivé, A Schreiner, et al.
Neurology
|
May 19, 2010
The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO
C Fratter, G S Gorman, J D Stewart, et al.
Neuromuscular Disorders : NMD
|
August 18, 2021
1st FSHD European Trial Network workshop:Working towards trial readiness across Europe
N C Voermans, M Vriens-Munoz Bravo, G W Padberg, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
European Journal of Neurology
|
January 31, 2026
EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemia
T Kyriakides, K Aleksovska, C Angelini, et al.
Journal of Neuromuscular Diseases
|
November 25, 2017
Early-Onset Myopathies: Clinical Findings, Prevalence of Subgroups and Diagnostic Approach in a Single Neuromuscular Referral Center in Germany
K Vill, A Blaschek, D Gläser, et al.
European Journal of Neurology
|
May 7, 2017
European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience
A T van der Ploeg, M E Kruijshaar, A Toscano, et al.
Neuropathology and Applied Neurobiology
|
September 24, 2019
An integrative correlation of myopathology, phenotype and genotype in late onset Pompe disease
M Kulessa, I Weyer-Menkhoff, L Viergutz, et al.
Acta Neuropathologica Communications
|
February 5, 2016
New insights into the protein aggregation pathology in myotilinopathy by combined proteomic and immunolocalization analyses
A Maerkens, M Olivé, A Schreiner, et al.
Neurology
|
May 19, 2010
The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO
C Fratter, G S Gorman, J D Stewart, et al.
Neuromuscular Disorders : NMD
|
August 18, 2021
1st FSHD European Trial Network workshop:Working towards trial readiness across Europe
N C Voermans, M Vriens-Munoz Bravo, G W Padberg, et al.
Page
of 4